Restoring the body with gene therapy.
Tap on icon for description, click on resource name for more details.
Company that uses genome editing technologies to deliver regenerative medicine solutions
Company that provides essential products and services to help pharmaceutical and biotechnology companies
Company developing transformative gene-based medicines for serious human diseases
Eagle Genomics innovates at the intersection of biology, data sciences and bioinformatics
Company that develops novel medicinal products intended to restore health and prevent bacterial infections
Biotechnology company focused on developing liver directed gene therapies for a range of diseases
Gene editing company that designs & engineers genetically-modified cells, applying them to advance human health
Company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies
Health-care service company with a proprietary biomarker discovery platform
Gene and cell therapy company specialising in the development of gene-based medicines
Gene Therapy Blog Posts
Perfect storm for gene therapy?
Six of the best from Ray's newsletter
Turning off abnormal genes may cure crippling genetic disease
BBC - 21-Oct-2021
Potential gene silencing approach in porphyria and possibly for many other diseases in the futureRead more...
FDA puts clinical hold on Allogenic CAR T therapy due to safety concerns
FierceBiotech - 08-Oct-2021
Chromosome abnormality reported in a clinical trial raises doubts on patient safetyRead more...
OMEGA, a new powerful gene-editing system similar to CRISPR or so much better
New Atlas - 16-Sep-2021
Potential RNA-guiding enzymes that are capable of editing and modifying DNA in human cellsRead more...
Centaura's human artificial chromosome to treat complex diseases, including ageing
Medium - 10-Sep-2021
A breakthrough technology focusing on effective gene therapies for healthy longevityRead more...
Lifespan.io interviews George Church about gene therapy and longevity
Lifespan.io (LEAF) - 28-Jul-2021
Discusses animal trials, potential human trials, reeducating the FDA and improvements in technologyRead more...